Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Loreta Anesti KondiliSarah Robbins ScottSarah BlachIvane GamkrelidzeAnna Linda ZignegoMaurizia R BrunettoGiovanni RaimondoGloria TalianiAndrea IannoneFrancesco P RussoTeresa A SantantonioMassimo ZuinLuchino ChessaPierluigi BlancMassimo PuotiMaria VinciElke M ErneMario StrazzaboscoMarco MassariPietro LamperticoMaria G RumiAlessandro FedericoAlessandra OrlandiniAlessia CiancioGuglielmo BorgiaPietro AndreoneNicola CaporasoMarcello PersicoDonatella IeluzziSalvatore MadoniaAndrea GoriAntonio GasbarriniCarmine CoppolaGiuseppina BrancaccioAngelo AndriulliMaria Giovanna QuarantaSimona MontillaHomie RazaviMario MelazziniStefano VellaLoreta A Kondilinull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
In Italy, which is an HCV endemic country, the eligible pool of patients to treat will run out between 2025 and 2028. To maintain the treatment rate and achieve the HCV elimination goals, increased case finding in targeted, high prevalence groups is required.